Our bioresorbable scaffold supports lumen patency during healing while avoiding a permanent implant
Bioresorbable Scaffold Technology
480 Biomedical’s Stanza™ self-expanding scaffold employs a unique composite design that strikes an optimal balance of strength, flexibility and bioresorption.
Our Lead Application: Peripheral Artery Disease
Our lead product is the proprietary Stanza™ bioresorbable scaffold and delivery system for use in treating peripheral artery disease in the superficial femoral artery, a condition that is poorly addressed today.
News
Charing Cross
April 16, 2012
480 Biomedical announced today that it has initiated the first human trial of its groundbreaking Stanza™ self-expanding bioresorbable scaffold for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA).
Products presented in this website are not available for sale or distribution and are limited to clinical investigational use only.
© 2012 480 Biomedical. All rights reserved.
